BEMA® Products
Onsolis®
Onsolis® fentanyl buccal soluble film
BEMA® Buprenorphine
BioDelivery Sciences is developing BEMA® Buprenorphine for the potential treatment of acute and chronic pain conditions.
Other BEMA® Products
Other products utilizing the BEMA® technology are currently being explored.
BEMA® Technology
BEMA® Drug Delivery
BEMA® Drug Placement
BEMA® film layers
The BEMA® drug delivery technology is a buccal soluble film consisting of a small, bioerodible polymer film for application to the mucosal membranes (inner lining of cheek). BEMA® films were designed to rapidly deliver a dose of drug across the mucous membranes for time sensitive conditions.
BEMA® films are designed to:
- Adhere to oral mucosa in less than 5 seconds
- Optimize delivery across the oral mucosa
- Completely dissolve within 15 to 30 minutes
The first product use of the BEMA® technology is Onsolis® (fentanyl buccal soluble film). The BEMA® technology may also be developed with other active drugs, particularly in conditions where rapid delivery of drug is important, oral dosing is not optimal, or where intravenous lines or injections are unavailable or not practical. BDSI® owns the worldwide rights to the BEMA® drug delivery technology.